之江生物：公司在创新药与AI医疗领域均有布局

Core Viewpoint - The company, Zhijiang Biology (688317.SH), is actively engaged in the fields of innovative drugs and AI healthcare, focusing on an integrated strategy of "prevention, diagnosis, and treatment" [2]. Group 1: Company Strategy - The company emphasizes continuous development driven by innovation [2]. - It has established a presence in both innovative drugs and AI healthcare sectors [2]. - The company leverages technologies such as intelligent manufacturing and digital twins to enhance solutions in various fields, including infectious diseases, reproductive health, cancer, and genetic disease diagnostics [2].